Open AccessThe effects of Cynara scolymus L. supplementation on liver enzymes: A systematic review and meta‐analysis
Author(s) -
Moradi Sajjad,
ShokriMashhadi Nafiseh,
SarafBank Sahar,
Mohammadi Hamed,
Zobeiri Mehdi,
Clark Cain C. T.,
Rouhani Mohammad Hossein
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14726
Subject(s) - medicine , meta analysis , cochrane library , alanine transaminase , fatty liver , subgroup analysis , placebo , aspartate transaminase , medline , gastroenterology , publication bias , liver enzyme , traditional medicine , enzyme , disease , alkaline phosphatase , biochemistry , pathology , alternative medicine , biology
Objective A systematic review and meta‐analysis was conducted to summarise studies conducted on the effects of artichoke supplementation on liver enzymes. Methods Suitable studies were detected by searching online databases, including Medline, Embase, Cochrane Library, and Scopus databases, until 05 June 2021. As liver enzymes were reported in different units, standardised mean differences (SMD) were used and data were pooled using a random‐effects model. Heterogeneity, publication bias, and sensitivity analysis were also assessed. Results Pooled analysis, of eight clinical trials, revealed that artichoke supplementation significantly reduced the concentration of aspartate aminotransferase (AST) ( P = .001) and alanine transaminase (ALT) ( P = .016), in comparison with placebo. Subgroup analysis suggested that artichoke administration significantly reduces AST and ALT in patients with non‐alcoholic fatty liver disease ( P = .003 for AST and P < .001 for ALT), and ALT among overweight/obese subjects ( P = .025). Conclusions Artichoke supplementation elicited significant reductions in liver enzymes, especially among patients with non‐alcoholic fatty liver disease.